These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Update of epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer. Chen YM J Chin Med Assoc; 2013 May; 76(5):249-57. PubMed ID: 23683257 [TBL] [Abstract][Full Text] [Related]
11. Role of tyrosine kinase inhibitors in the treatment of advanced colorectal cancer. Grávalos C; Cassinello J; Fernández-Rañada I; Holgado E Clin Colorectal Cancer; 2007 Nov; 6(10):691-9. PubMed ID: 18039422 [TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers. Roskoski R Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458 [TBL] [Abstract][Full Text] [Related]
14. Molecular predictors of efficacy to anti-EGFR agents in colorectal cancer patients. Ruzzo A; Graziano F; Canestrari E; Magnani M Curr Cancer Drug Targets; 2010 Feb; 10(1):68-79. PubMed ID: 20088793 [TBL] [Abstract][Full Text] [Related]
15. Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancer. Subramaniam D; He AR; Hwang J; Deeken J; Pishvaian M; Hartley ML; Marshall JL Curr Cancer Drug Targets; 2015; 14(9):775-93. PubMed ID: 25435079 [TBL] [Abstract][Full Text] [Related]
16. The ErbB/HER family of protein-tyrosine kinases and cancer. Roskoski R Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963 [TBL] [Abstract][Full Text] [Related]
17. Targeting the epidermal growth factor receptor in metastatic colorectal cancer. Ng K; Zhu AX Crit Rev Oncol Hematol; 2008 Jan; 65(1):8-20. PubMed ID: 18006328 [TBL] [Abstract][Full Text] [Related]